CHRONIC LYMPHOCYTIC LEUKAEMIA (IN REMISSION)

This adverse event was reported 9 times

CHRONIC LYMPHOCYTIC LEUKAEMIA (IN REMISSION) is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 QUERCETIN 1 0.0008
1 IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE 1 0.0002
2 BENDAMUSTINE HYDROCHLORIDE 1 0.0001
3 PEGFILGRASTIM 1 0.0001
4 KETOCONAZOLE FOAM 1 0.0001
5 ROMIPLOSTIM 1 0.0001
6 KETOCONAZOLE CREAM, 2% 1 0.0001
7 KETOCONAZOLE 1 0.0001
8 PRAVASTATIN SODIUM 1 0.0000
9 ELTROMBOPAG OLAMINE 1 0.0000
See all drugs enriched for association with CHRONIC LYMPHOCYTIC LEUKAEMIA (IN REMISSION)